G. Güncan Et Al. , "Formulation design of the oral disintegrating tablets including alfuzosin hydrochloride with risk evaluation via quality by design," Acta Pharmaceutica Sciencia , vol.55, pp.57-76, 2017
Güncan, G. Et Al. 2017. Formulation design of the oral disintegrating tablets including alfuzosin hydrochloride with risk evaluation via quality by design. Acta Pharmaceutica Sciencia , vol.55 , 57-76.
Güncan, G., Yeğen, G., Mesut, B., Aksu, B., & Özsoy, Y., (2017). Formulation design of the oral disintegrating tablets including alfuzosin hydrochloride with risk evaluation via quality by design. Acta Pharmaceutica Sciencia , vol.55, 57-76.
Güncan, Gözde Et Al. "Formulation design of the oral disintegrating tablets including alfuzosin hydrochloride with risk evaluation via quality by design," Acta Pharmaceutica Sciencia , vol.55, 57-76, 2017
Güncan, Gözde Et Al. "Formulation design of the oral disintegrating tablets including alfuzosin hydrochloride with risk evaluation via quality by design." Acta Pharmaceutica Sciencia , vol.55, pp.57-76, 2017
Güncan, G. Et Al. (2017) . "Formulation design of the oral disintegrating tablets including alfuzosin hydrochloride with risk evaluation via quality by design." Acta Pharmaceutica Sciencia , vol.55, pp.57-76.
@article{article, author={Gözde Güncan Et Al. }, title={Formulation design of the oral disintegrating tablets including alfuzosin hydrochloride with risk evaluation via quality by design}, journal={Acta Pharmaceutica Sciencia}, year=2017, pages={57-76} }